brequinar has been researched along with Hematologic Diseases in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dodion, P; Gall, H; Joggi, J; Schwartsmann, G; Simonetti, G; ten Bokkel Huinink, WW; van der Vijgh, WJ; van Hennik, MB; Vermorken, JB; Winograd, B | 1 |
1 other study(ies) available for brequinar and Hematologic Diseases
| Article | Year |
|---|---|
Phase I study of Brequinar sodium (NSC 368390) in patients with solid malignancies.
Topics: Adult; Aged; Antineoplastic Agents; Biphenyl Compounds; Drug Evaluation; Female; Hematologic Diseases; Humans; Infusions, Intravenous; Leukocyte Count; Male; Middle Aged; Neoplasms; Platelet Count | 1990 |